Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating Mycobacterium abscessus
Mycobacterium abscessus infections are increasing worldwide. Current drug regimens are largely ineffective, yet the current development pipeline for M. abscessus is alarmingly sparse. Traditional discovery efforts for M. abscessus assess the capability of a new drug to inhibit bacterial growth under...
Main Authors: | Bryan J. Berube, Lina Castro, Dara Russell, Yulia Ovechkina, Tanya Parish |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.02417/full |
Similar Items
-
Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
by: Nguyen Thanh Quang, et al.
Published: (2021-08-01) -
Mycobacterium abscessus Complex Infections in Humans
by: Meng-Rui Lee, et al.
Published: (2015-09-01) -
Mycobacterium abscessus Opsonization Allows an Escape from the Defensin Bactericidal Action in Drosophila
by: Hamadoun Touré, et al.
Published: (2023-08-01) -
Etymologia: Mycobacterium abscessus subsp. bolletii
Published: (2014-03-01) -
Mycobacterium abscessus Endocarditis: A Case Report and Literature Review
by: Wei-Chung Tsai, et al.
Published: (2008-09-01)